Recent Quarter Total Invested
$2.81 B
Recent Quarter Institutional Ownership Percentage
69.72%
Total Invested of Last Quarter
$3.22 B
Ownership Percentage of Last Quarter
72.83%
CRISPR Therapeutics AG Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2024 | 7.93 M | $372.40 M | 0.78% | 9.30% |
| ARK INVESTMENT MANAGEMENT LLC | 10/31/2024 | 7.50 M | $352.29 M | -3.60% | 8.80% |
| STATE STREET CORP | 11/14/2024 | 2.99 M | $140.61 M | 25.04% | 3.51% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 11/05/2024 | 2.97 M | $139.44 M | -5.82% | 3.48% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 11/07/2024 | 2.97 M | $139.37 M | -5.85% | 3.48% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.80 M | $131.32 M | 100.00% | 3.28% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 2.74 M | $128.61 M | 0.25% | 3.21% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 1.59 M | $74.60 M | 0.00% | 1.86% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 1.39 M | $65.27 M | 0.00% | 1.63% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 1.08 M | $50.82 M | 14.89% | 1.27% |
| SR ONE CAPITAL MANAGEMENT, LP | 11/13/2024 | 1.05 M | $49.28 M | 0.00% | 1.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.01 M | $47.38 M | 3.62% | 1.18% |
| LOOMIS SAYLES & CO L P | 11/13/2024 | 945,267 | $44.41 M | -6.06% | 1.11% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 843,075 | $39.61 M | 743.08% | 0.99% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 824,606 | $38.74 M | -13.21% | 0.97% |
| CONTRARIUS INVESTMENT MANAGEMENT LTD | 11/08/2024 | 783,898 | $36.83 M | 14.32% | 0.92% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 724,241 | $34.02 M | 0.92% | 0.85% |
| CITADEL ADVISORS LLC | 11/14/2024 | 695,400 | $32.67 M | -2.17% | 0.82% |
| UBS GROUP AG | 11/14/2024 | 673,588 | $31.65 M | 58.78% | 0.79% |
| MORGAN STANLEY | 11/14/2024 | 632,003 | $29.69 M | 5.74% | 0.74% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 623,650 | $29.30 M | 587.87% | 0.73% |
| BELLEVUE GROUP AG | 11/14/2024 | 610,000 | $28.66 M | -1.24% | 0.72% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 604,700 | $28.41 M | 25.87% | 0.71% |
| CITADEL ADVISORS LLC | 11/14/2024 | 518,547 | $24.36 M | 263.73% | 0.61% |
| VERSANT VENTURE MANAGEMENT, LLC | 11/08/2024 | 498,558 | $23.42 M | 0.00% | 0.58% |
| BAILLIE GIFFORD & CO | 11/05/2024 | 364,768 | $17.14 M | -10.03% | 0.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 358,903 | $16.86 M | 37.61% | 0.42% |
| JPMORGAN CHASE & CO | 11/08/2024 | 354,242 | $16.64 M | 7.65% | 0.42% |
| CAPITAL ADVISORS INC/OK | 10/28/2024 | 300,589 | $14.12 M | 8.12% | 0.35% |
| CITADEL ADVISORS LLC | 11/14/2024 | 280,000 | $13.15 M | -24.53% | 0.33% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 266,500 | $12.52 M | -15.80% | 0.31% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 263,400 | $12.37 M | -25.17% | 0.31% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 248,979 | $11.70 M | -7.38% | 0.29% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 214,094 | $10.06 M | 17.27% | 0.25% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 209,840 | $9.86 M | -20.92% | 0.25% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 203,029 | $9.54 M | -10.80% | 0.24% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 200,000 | $9.40 M | 0.83% | 0.23% |
| EAGLE HEALTH INVESTMENTS LP | 11/12/2024 | 197,000 | $9.26 M | 0.00% | 0.23% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 186,761 | $8.77 M | 14.66% | 0.22% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 179,053 | $8.41 M | 949.61% | 0.21% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 11/14/2024 | 174,097 | $8.18 M | -11.90% | 0.20% |
| CAPITAL INTERNATIONAL SARL | 11/13/2024 | 170,523 | $8.01 M | 14.14% | 0.20% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 166,263 | $7.81 M | 100.00% | 0.20% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 159,644 | $7.55 M | 0.00% | 0.19% |
| SWISS NATIONAL BANK | 11/07/2024 | 157,600 | $7.40 M | -0.69% | 0.18% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 150,000 | $7.05 M | 0.00% | 0.18% |
| BARCLAYS PLC | 11/19/2024 | 129,848 | $6.10 M | 97.88% | 0.15% |
| CAPITAL INTERNATIONAL LTD /CA/ | 11/13/2024 | 125,604 | $5.90 M | -0.42% | 0.15% |
| BLAIR WILLIAM & CO/IL | 11/12/2024 | 121,909 | $5.73 M | -9.68% | 0.14% |
| ROYAL BANK OF CANADA | 11/14/2024 | 120,171 | $5.65 M | 39.08% | 0.14% |
CRISPR Therapeutics AGinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CRSP shares?
During the previous two years, 533 institutional investors and hedge funds held shares of CRISPR Therapeutics AG. The most heavily invested institutionals were:
Capital International Investors: 7.93 M
ARK Investment Management LLC: 7.5 M
STATE STREET CORP: 2.99 M
Sumitomo Mitsui Trust Holdings, Inc.: 2.97 M
Nikko Asset Management Americas, Inc.: 2.97 M
BlackRock Funding, Inc. /DE: 2.8 M
-
What percentage of CRISPR Therapeutics AG stock is owned by institutional investors?
69.72% of CRISPR Therapeutics AG stock is owned by institutional investors.
-
How much institutional buying is happening at CRSP ?
Institutional investors have bought a total of 59.39 M shares in the last 24 months. This purchase volume represents approximately $2.75 B in transactions.